{"id":"742638d05092","type":"article","url":"https://hartvaat.nl/2026/03/06/kdigo-consensusconferentie-uitdagingen-bij-gecombineerd-hartfalen-en-nierziekte/","title":"KDIGO-consensusconferentie: uitdagingen bij gecombineerd hartfalen en nierziekte","title_en":"Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","category":"chronische nierziekte","category_label":"Nierziekte","professions":["cardioloog","internist"],"tags":["acuut-hartfalen","cardiorenal-behandelstrategie"],"journal":"Kidney International","doi":"https://www.kidney-international.org/article/S0085-2538(25)00884-1/fulltext","source_url":"https://doi.org/https://www.kidney-international.org/article/S0085-2538(25)00884-1/fulltext","authors":["Carolyn S.P. Lam","Biykem Bozkurt","David Z.I. Cherney","Justin A. Ezekowitz","Meg J. Jardine","Sadiya S. Khan","Magdalena Madero","Mark J. Sarnak","Jozine M. ter Maaten","Michael Cheung","Jennifer M. King","Morgan E. Grams","Michel Jadoul","Nisha Bansal","Conference Participants"],"significance":8,"published":"2026-03-15","source_date":"2026-03-06","image":"","kennis":["https://hartvaat.nl/kennis/nierziekte/kdigo-richtlijn-ckd-2024/","https://hartvaat.nl/kennis/nierziekte/nsaids-en-nierziekte/"],"congress":"","summary_en":"This KDIGO consensus conference summary addressed the intersection of heart failure and chronic kidney disease, reviewing advances in cardiorenal understanding and the challenges of managing patients with both conditions, including the role of SGLT2 inhibitors and finerenone.","created":"2026-07-03T10:32:34Z","updated":"2026-07-03T18:39:27Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Hartfalen en chronische nierziekte komen frequent samen voor en verhogen het risico op hospitalisatie en overlijden aanzienlijk. Deze KDIGO-consensusconferentie brengt de complexe bidirectionele interactie in kaart en identificeert diagnostische en therapeutische uitdagingen bij gecombineerd cardiorenal falen. Met SGLT2-remmers en finerenon als game-changers biedt dit rapport een actueel overzicht van de stand van wetenschap.","abstract_original":"Heart failure (HF) and chronic kidney disease (CKD) frequently coexist, which elevates the risks of hospitalization, disease progression, and death. Despite advances in treating each condition independently, many challenges remain in diagnosing and managing them in combination. In March 2024, Kidney Disease: Improving Global Outcomes (KDIGO) held the Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. Discussions highlighted the complex, bidirectional relationship between HF and CKD, including shared risk factors and overlapping pathophysiology as well as nuances in interpreting biomarkers such as natriuretic peptides and serum creatinine."}